Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 11/2018

01-11-2018 | Review Article

Human papillomavirus and colorectal cancer

Authors: Marina K. Ibragimova, Matvey M. Tsyganov, Nicolay V. Litviakov

Published in: Medical Oncology | Issue 11/2018

Login to get access

Abstract

The involvement of human papillomavirus in carcinogenesis of colorectal cancer is a contentious issue. The presented meta-analysis was performed to systematize the currently available research results on the matter. The analysis was based on the data from 19 studies to assess the association of HPV infection with colorectal cancer. According to the obtained data, researchers determined the statistically significant level of HPV infection in tumor tissue of CRC and the resulting relative risk of developing CRC with HPV infection to be RR (95% CI) = 2.97 (1.42–6.22) with p = 0.0039.
Literature
1.
DeBarros M, et al. Outcome comparison following colorectal cancer surgery in an equal access system. J Surg Res. 2013;184(1):507–13.CrossRefPubMed
2.
3.
Mitchell EP. Targeted therapy for metastatic colorectal cancer: role of aflibercept. Clin Colorectal Cancer. 2013;12(2):73–85.CrossRefPubMed
4.
5.
Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed
6.
Kaprin AD, et al. Malignant neoplasms in Russia in 2013 (morbidity and mortality). Moscow: FGBU “MNIOI im. P.A. Herzen” Ministry of Health and Social Development of Russia; 2013.
7.
Mansouri D, et al. Screening for colorectal cancer: What is the impact on the determinants of outcome? Crit Rev Oncol/Hematol. 2013;3(85):342–9.CrossRef
8.
Soto Y, et al. Molecular evidence of high-risk human papillomavirus infection in colorectal tumours from Cuban patients. Memórias do Instituto Oswaldo Cruz. 2016;111(12):731–6.CrossRefPubMedPubMedCentral
9.
10.
Uspenskaya Yu. et al. Gender aspects of prevention and screening of colorectal cancer in women. Gynecology. 2013;1:80–4.
11.
12.
Parkin DM. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010: Introduction. Br J Cancer. 2011;105(Suppl 2):2.CrossRef
13.
Ibragimova М, et al. Integrative and episomal forms 16 genotypes of human papillomavirus for cervical intraepithelial neoplasia and cervical cancer. Probl Virol. 2016; 61:6.
14.
Bychkov V, et al. Comprehensive meta-analytical summary on human papillomavirus association with head and neck cancer. Exp Oncol. 2016;38(2):68–72.PubMed
15.
Ferlay J, et al. Cancer incidence and mortality worldwide, international agency for research on cancer. Lyon: Cancer Incidence and Mortality Worldwide, International Agency for Research on Cancer; 2013.
16.
Hampl M, et al. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol. 2006;108(6):1361–8.CrossRefPubMed
17.
Beckmann AM, et al. Human papillomavirus infection and anal cancer. Int J Cancer. 1989;43(6):1042–9.CrossRefPubMed
18.
19.
Boguszakova L, et al. Absence of cytomegalovirus, Epstein-Barr virus, and papillomavirus DNA from adenoma and adenocarcinoma of the colon. Acta Virol. 1988;32(4):303–8.PubMed
20.
Yavuzer D, et al. Investigation of human papillomavirus DNA in colorectal carcinomas and adenomas. Med Oncol. 2011;28(1):127–32.CrossRefPubMed
21.
Gornick MC, et al. Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes Control. 2010;21(5):737–43.CrossRefPubMedPubMedCentral
22.
Karpinski P, et al. Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype. Tumor Biol. 2011;32(4):653–9.CrossRef
23.
Snietura M, et al. Does human papilloma virus participate in colorectal carcinogenesis. J Biol Regul Homeost Agents. 2012;26:757–62.PubMed
24.
Lee Y, et al. Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect. 2001; 34(2): 87–91.PubMed
25.
Giuliani L, et al. Detection of oncogenic DNA viruses in colorectal cancer. Anticancer Res. 2008;28(2B):1405–10.PubMed
26.
Ghabreau L, et al. High-risk human papillomavirus infections in colorectal cancer in the Syrian population and their association with Fascin, Id-1 and P-cadherin expressions: a tissue microarray study. Clin Cancer Invest J. 2012;1(1):26.CrossRef
27.
28.
Salepci T, et al. Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients. J BU ON. 2009;14(3):495–9.
29.
Deschoolmeester V, et al. Detection of HPV and the role of p16 INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. BMC Cancer. 2010;10(1):117.CrossRefPubMedPubMedCentral
30.
Pérez LO, et al. Human papillomavirus DNA and oncogene alterations in colorectal tumors. Pathol Oncol Res. 2010;16(3):461–8.CrossRefPubMed
31.
McGregor B, et al. Confirmation of the association of human papillomavirus with human colon cancer. Am J Surg. 1993;166(6):738–42.CrossRefPubMed
32.
Yu H-G, et al. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection. Int J Colorectal Dis. 2002;17(6):396–401.CrossRefPubMed
33.
Cavatorta AL, et al. Differential expression of the human homologue of drosophila discs large oncosuppressor in histologic samples from human papillomavirus–associated lesions as a marker for progression to malignancy. Int J Cancer. 2004;111(3):373–80.CrossRefPubMed
34.
35.
Perez L, et al. Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction. Colorectal Dis. 2005;7(5):492–5.CrossRefPubMed
36.
Damin DdC, et al. Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol. 2007;33(5):569–74.CrossRefPubMed
37.
Militello V, et al. Investigation on the presence of polyomavirus, herpesvirus, and papillomavirus sequences in colorectal neoplasms and their association with cancer. Int J Cancer. 2009;124(10):2501–3.CrossRefPubMed
38.
Liu F, et al. Prevalence of human papillomavirus in Chinese patients with colorectal cancer. Colorectal Dis. 2011;13(8):865–71.CrossRefPubMed
39.
40.
Toru S, Bilezikçi B. Early changes in carcinogenesis of colorectal adenomas. West Indian Med J. 2012;61(1):10–6.CrossRefPubMed
41.
Burnett-Hartman AN, et al. Human papillomavirus DNA is rarely detected in colorectal carcinomas and not associated with microsatellite instability: the Seattle colon cancer family registry. Cancer Epidemiol Prev Biomark. 2013;22(2):317–9.CrossRef
42.
Taherian H, et al. Lack of association between human papillomavirus infection and colorectal cancer. Prz Gastroenterol. 2014;9(5):280.PubMedPubMedCentral
43.
Tanzi E, et al. Human papillomavirus detection in paraffin-embedded colorectal cancer tissues. J Gen Virol. 2015;96(1):206–9.CrossRefPubMed
44.
45.
Vuitton L, et al. Human papillomaviruses in colorectal cancers: A case-control study in western patients. Dig Liver Dis. 2017;49(4):446–50.CrossRefPubMed
46.
Chen T-H, et al. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. World J Gastroenterol WJG. 2012;18(30):4051.CrossRefPubMed
47.
Lorenzon L, et al. Human papillomavirus does not have a causal role in colorectal carcinogenesis. World J Gastroenterol WJG. 2015;21(1):342.CrossRefPubMed
48.
Kachalina OV, et al. Modern ideas about the role of human papillomavirus in the genesis of cervical cancer (review). Med Alm. 2011;5:116–20.
49.
Vink MA, et al. Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data. Am J Epidemiol. 2013;178:1161–9.CrossRefPubMed
50.
Hu Z, et al. Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism. Nat Genet. 2015;47(2):158–63.CrossRefPubMed
Metadata
Title
Human papillomavirus and colorectal cancer
Authors
Marina K. Ibragimova
Matvey M. Tsyganov
Nicolay V. Litviakov
Publication date
01-11-2018
Publisher
Springer US
Published in
Medical Oncology / Issue 11/2018
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-018-1201-9

Other articles of this Issue 11/2018

Medical Oncology 11/2018 Go to the issue

Original Paper

Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis

Review Article

Imaging of distant metastases of prostate cancer

Letter to the Editor

The critical role of comorbidities and polypharmacy in lower risk myelodysplastic patients: is there any difference between countries?

Original Paper

DNA methylation marker to estimate the breast cancer cell fraction in DNA samples

Original Paper

Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis

Original Paper

Overall survival of Brazilian acute myeloid leukemia patients according to the European LeukemiaNet prognostic scoring system: a cross-sectional study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits